12/4/2020  5:52:15 PM Chg. -0.0050 Volume Bid7:44:00 PM Ask6:15:33 PM Market Capitalization Dividend Y. P/E Ratio
3.0500EUR -0.16% 9,036
Turnover: 27,476.0500
-Bid Size: - -Ask Size: - 136.34 mill.EUR 0.00% -

Business description

Biofrontera AG is a biopharmaceutical company specializing on the development of drugs and medicinal cosmetics for the treatment of skin diseases and the regenerative care of damaged skin. Headquartered in Leverkusen, Germany, Biofrontera is a publicly listed on the Frankfurt Stock Exchange (Prime Standard) and London Stock Exchange (AIM) – B8F / ISIN: DE 0006046113. In February 2012 Biofrontera launched its prescription drug Ameluz® for the treatment of actinic keratosis on the German market. In other European countries Ameluz® is marketed through local partners. Ameluz® is applied in Photodynamic Therapy requiring a powerful source of red light. For this purpose Biofrontera has developed the BF-RhodoLED® lamp, which was CE marked in November 2012. As cosmeceutical products Biofrontera markets Belixos® for the regenerative care of reddened and inflamed skin. Biofrontera developed a line of cosmeceutical products for damaged skin under the Belixos brand. The product portfolio includes the Belixos® cream, Belixos LIQUID®, Belixos® GEL and DayCare cream Belixos® PROTECT.

Management board & Supervisory board

Prof. Dr. Hermann Lübbert
Management board
Thomas Schaffer
Supervisory board
Dr. Ulrich Granzer, Jürgen Baumann, Dr. John Borer, Kevin Weber, Prof. Dr. Franca Ruhwedel, Reinhard Eyring

Company data

Name: Biofrontera AG
Address: Hemmelrather Weg 201,D-51377 Leverkusen
Phone: +49-214-87632-0
Fax: +49-214-87632-90
E-mail: info@biofrontera.com
Internet: www.biofrontera.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 34.29%
IPO date: -

Investor relations

Name: Anke zur Mühlen
IR phone: -
IR Fax: -
IR e-mail: ir@biofrontera.com

Main Shareholders

Wilhelm K. T. Zours (Deutsche Balaton - Group)
Maruho Co., Ltd.
Lang & Schwarz Broker GmbH